Door-Through-Door Companion Rideshare Technology for Individuals With Alzheimer's Disease
The goal of this pilot randomized controlled trial is to assess the impact of D2D rideshare services with a trained companion driver on the rate of medical appointments for older adults and individuals with AD/ADRD. Participants will be assigned either door-through-door (D2D) rideshare or curb-to-curb (C2C) rideshare s
| Condition(s) | Alzheimer Disease or Associated Disorder, Dementia, Cognitive Decline |
|---|---|
| Status | Recruiting |
| Phase | Phase 1 |
| Study type | Interventional |
| Summary | The goal of this pilot randomized controlled trial is to assess the impact of D2D rideshare services with a trained companion driver on the rate of medical appointments for older adults and individuals with AD/ADRD. Participants will be assigned either door-through-door (D2D) rideshare or curb-to-curb (C2C) rideshare services. he main question it aims to answer is: Do D2D rideshare services reduce missed medical appointment rates compared to C2C rideshare services? |
| Who can participate | Inclusion Criteria: * All participants (or their surrogate) have the capacity to agree to allow Onward service for transportation; * have scheduled medical appointments at partner practices of Onward; * ages 60+ * community-dwelling; * 60 participants who self-reported cognitive problems, such as memory issue, or have mild cognitive impairment, subjective cognitive decline, or AD/ADRD diagnosis * Resides and attends appointments in the following San Francisco Bay Area Counties (San Francisco, Alameda, Contra Costa, Marin, San Mateo, Sonoma) Exclusion Criteria: * current enrollment in another transportation study; * already using any type of free or heavily subsized transportation service; * enrollees with comfort care only; * Not wheelchair bound, e.g. if using a wheelchair must be foldabl |
| Ages | 60 Years |
| Sex | All |
| Accepts healthy volunteers | Yes |
| Lead sponsor | Onward Health, Inc |
| Locations | San Leandro, California, United States |
| Start date | 2025-08-29 |
| NCT ID | NCT06850870 |
| Official listing | https://clinicaltrials.gov/study/NCT06850870 |